# Valvosoft Outcomes Registry for Real-World Evidence

> **NCT07520591** · — · NOT_YET_RECRUITING · sponsor: **Cardiawave SA** · enrollment: 200 (estimated)

## Conditions studied

- Aortic Valve Disease
- Aortic Stenosis, Severe
- Aortic Valve Calcification
- Ultrasound Therapy
- Heart Failure

## Interventions

- **DEVICE:** Valvosoft Treatment

## Key facts

- **NCT ID:** NCT07520591
- **Lead sponsor:** Cardiawave SA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-30
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07520591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07520591, "Valvosoft Outcomes Registry for Real-World Evidence". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07520591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*